| scholarly article | Q13442814 |
| P356 | DOI | 10.1191/0961203304LU1011OA |
| P698 | PubMed publication ID | 15303568 |
| P50 | author | Yehuda Shoenfeld | Q1515807 |
| P2093 | author name string | G Szegedi | |
| Z Szekanecz | |||
| K Veres | |||
| A Kerényi | |||
| G Lakos | |||
| P Soltész | |||
| P433 | issue | 6 | |
| P921 | main subject | acute coronary syndrome | Q266018 |
| P304 | page(s) | 423-427 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Lupus | Q6704846 |
| P1476 | title | Antiphospholipid antibodies in acute coronary syndrome | |
| P478 | volume | 13 |
| Q83366916 | A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima-media in patients with systemic autoimmune diseases |
| Q36746012 | Accelerated atherosclerosis in patients with chronic inflammatory rheumatologic conditions |
| Q42283118 | Anti-Phosphatidylserine-Prothrombin Antibodies are Associated with Outcome in a TIA Cohort |
| Q80290775 | Antibodies against oxidized phospholipids in laboratory tests exploring lupus anti-coagulant activity |
| Q37824302 | Auto-antibodies as emergent prognostic markers and possible mediators of ischemic cardiovascular diseases |
| Q64262888 | Cardiac Manifestations of Antiphospholipid Syndrome With Focus on Its Primary Form |
| Q34495257 | Cardiovascular disease in rheumatoid arthritis: a systematic literature review in latin america |
| Q34081242 | Cardiovascular involvement in autoimmune diseases |
| Q41732431 | Circulating Anti-Coatomer Protein Complex Subunit Epsilon (COPE) Autoantibodies as a Potential Biomarker for Cardiovascular and Cerebrovascular Events in Patients with Obstructive Sleep Apnea |
| Q55414008 | Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea. |
| Q37853050 | Cutting-edge issues in coronary disease and the primary antiphospholipid syndrome |
| Q33937755 | Heart failure in a woman with SLE, anti-phospholipid syndrome and Fabry's disease |
| Q43672062 | IgA antibodies against β2 glycoprotein I in hemodialysis patients are an independent risk factor for mortality |
| Q36057246 | IgA anticardiolipin antibody is associated with the extent of daily-life ischaemia in patients with chronic coronary artery disease |
| Q37351603 | Independent association of anti-beta(2)-glycoprotein I antibodies with macrovascular disease and mortality in scleroderma patients |
| Q36932166 | Is preclinical autoimmunity benign?: The case of cardiovascular disease |
| Q33730536 | Management of cardiovascular complications in systemic lupus erythematosus |
| Q64108214 | New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches |
| Q37959316 | Potential use of statins in the treatment of antiphospholipid syndrome. |
| Q53643980 | Thrombophilic state in young patients with acute myocardial infarction. |
Search more.